CMS has negotiated a 71% discount off the list price, or $274 for a 30-day supply, on Novo Nordisk’s semaglutide products — Ozempic and Rybelsus for diabetes and Wegovy for weight loss — through the ...

Telehealth replaces 74% of office visits, according to the operational analysis of telehealth utilization from 2019 to 2023, ...

Ralph Abraham's appointment as CDC principal deputy director raises concerns due to his controversial vaccine stance and past actions as Louisiana's surgeon general. His appointment follows the forced ...

The FDA has approved Itvisma (onasemnogene abeparvovec-brve) to treat children two years and older, teens, and adults living with spinal muscular atrophy (SMA). It is indicated for patients with a ...

Beginning Jan. 1, 2026, Optum Rx, the pharmacy benefit manager of UnitedHealthcare, will reduce reauthorizations for an ...

It’s been discovered that a new tool using routine blood tests and a simple online app could help detect tuberculosis (TB) ...

ASTRO's new guidelines enhance radiation therapy strategies for gastric cancer, improving treatment outcomes and patient care ...

Manufacturers may prioritize developing drugs for rare diseases first, delaying negotiations for common condition treatments. A provision in the One Big Beautiful Bill delays or exempts high-spending ...

Integrating tobacco-cessation services into HIV and tuberculosis care can enhance treatment outcomes and reduce mortality. Health systems should implement comprehensive tobacco-cessation strategies, ...

Each Sunday we feature a highlight reel of various articles posted on our website that week.

Relmada Therapeutics is advancing NDV-01, a novel intravesical therapy for NMIBC, into phase 3 clinical trials, with Max ...

Public health experts warn that a major communication failure could worsen mistrust of vaccines, a problem brought to light ...